In This Section

Program

Please note that this meeting will take place as an in-person event in Philadelphia and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the REGISTRATION page for details. 

CME credit is available for in-person attendance for the designated sessions. On-demand presentations are not eligible for CME.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise.  Program is subject to change. 

Thursday, September 8

Welcome and Opening Lecture

Friday, September 9

Plenary Session 1: Pathology
Plenary Session 2: Artificial Intelligence
Plenary Session 3: Model Systems
Open Satellite Session: Updates from the Human Tumor Atlas Network and PRECISION Consortia

Saturday, September 10

Plenary Session 4: What is the role of our current surgical treatments?
Plenary Session 5: Imaging
Plenary Session 6: Controversies in Clinical Care (Debate Format)

Sunday, September 11

Plenary Session 7:  Molecular Sequencing
Plenary Session 8: Microenvironment

Thursday, September 8

CME Icon
Welcome and Opening Lecture
6:45 p.m.-7:30 p.m.

Welcome from Cochairs

Opening Presentation
Angela M. Belcher, Massachusetts Institute of Technology, Cambridge, Massachusetts

Opening Reception
7:30 p.m.-10:00 p.m.

Friday, september 9

Breakfast
7-8 A.M. 
CME Icon
Plenary Session 1: Pathology
Session Chair: Jorge S. Reis-Filho, Memorial Sloan Kettering Cancer Center, New York, New York 
8-10 A.M. 

DCIS: Pathological heterogeneity and prognosis definition 
Anne Vincent-Salomon, Institut Curie, Paris, France  

Title to be announced
Jorge S. Reis-Filho

Additional speakers to be announced

Short talks from proffered abstracts

Break
10–10:30 a.m.
CME Icon
Plenary Session 2: Artificial Intelligence
Session Chair: To be announced
10:30 a.m.–12:30 p.m. 

Title to be announced 
Andrew H. Beck, PathAI, Inc., Boston, Massachusetts

Title to be announced 
Yinyin Yuan, Institute for Cancer Research, London, United Kingdom 

Breast pathology and AI: Are we there yet? 
Matthew G. Hanna, Memorial Sloan Kettering Cancer Center, New York, New York  

Short talks from proffered abstracts

Poster Session A/ Lunch (provided)
12:30–2 p.m. 
CME Icon
Plenary Session 3: Model Systems
Session Chair: Jos Jonkers, Netherlands Cancer Institute, Amsterdam, The Netherlands
2:30-4:45 P.M.

Title to be announced
Fariba Behbod, University of Kansas Medical Center, Kansas City, Kansas

Title to be announced
Senthil K. Muthuswamy, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Title to be announced
Jos Jonkers, Netherlands Cancer Institute, Amsterdam, The Netherlands

Patient-derived organoids as models for breast cancer interception
Jennifer Rosenbluth, University of California, San Francisco, San Francisco, California

Break
4:45-5 P.M.
Open Satellite Session: Updates from the Human Tumor Atlas Network and PRECISION Consortia
Session Chairs: Robert West, Stanford University, Stanford, California and Jelle Wesseling, Netherlands Cancer Institute, Amsterdam, The Netherlands
5-7 P.M.

Session 1: Spatial Genomics 
Moderators: Robert West, Stanford University, Stanford, California and Esther H. Lips Netherlands Cancer Institute, Amsterdam, The Netherlands
5-5:45 P.M.

Mammary epithelial architecture modulates field cancerization
Hendrik Messal, Netherlands Cancer Institute, Amsterdam, The Netherlands

Title to be announced
Runmin Wei, UT MD Anderson Cancer Center, Houston, TX

Title to be announced
Marc D. Ryser, Duke University, Durham, North Carolina

Break
5:45-6 P.M.

Session 2: How Can We Optimize Risk Stratification Over Time for DCIS?
Moderators: Jelle Wesseling, Netherlands Cancer Institute, Amsterdam, The Netherlands
6-7 P.M.

Managing large-scale consortia
Jelle Wesseling

Title to be announced
Yinyin Yuan, Institute for Cancer Research, London, United Kingdom

Title to be announced
Jonas Teuwen, Netherlands Cancer Institute, Amsterdam, The Netherlands

Additional speakers to be announced

saturday, September 10

Breakfast
7–8 A.M.
CME Icon
Plenary Session 4: What is the role of our current surgical treatments?
Session Chair: To be announced
8-10 A.M.

Surgery for DCIS: If, what and when
Alistair Thompson, Dan L. Duncan Comprehensive Cancer Center, Houston, Texas

Title to be announced
Seema A. Khan, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois

The evolving role of surgery as precision care for DCIS
E. Shelley Hwang, Duke Cancer Institute, Durham, North Carolina

Short talks selected from proffered abstracts

Break
10-10:30AM
CME Icon
Plenary Session 5: Imaging
Session Chair: Heather Greenwood, University of California San Francisco, San Francisco, California
10:30 A.M.-12:30 P.M.

Title to be announced
Constance Lehman, Harvard University/Massachusetts General Hospital, Boston, Massachusetts

MR Imaging of active surveillance of DCIS – What we have learned so far
Heather Greenwood, UCSF, San Francisco, California

DCIS and MRI – Challenges and opportunities
Habib Rahbar, University of Washington School of Medicine, Seattle, Washington

Short talks from proffered abstracts

Lunch on own
12:30-2:30 P.M.
CME Icon
Plenary Session 6: Controversies in Clinical Care (debate format)  
Moderator: Laura J. Esserman, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
2:30–4:30 p.m.  

DCIS should not be called cancer
Jennifer L. Marti, Weill Cornell Medicine, New York, New York
Steven Narod, Women’s College Research Institute, Toronto, Canada
Discussion

It is time to rethink local therapy for DCIS–enhanced image guided radiation therapy
Nicolas D. Prionas, University of California San Francisco, San Francisco, California
Bruce Mann, Royal Melbourne Hospital, Parkville, Australia 
Discussion

POSTER SESSION B / RECEPTION
4:45-7 P.M.

Sunday, September 11

Breakfast
7-8 A.M.
CME Icon
Plenary Session 7:  Molecular Sequencing
Session Chair: Kornelia Polyak, Dana-Farber Cancer Institute, Boston, Massachusetts
8-9:45 A.M.

Spatial heterogeneity in DCIS
Therese Sørlie, Oslo University Hospital, Oslo, Norway

Title to be announced
Nicholas E. Navin, UT MD Anderson Cancer Center, Houston, Texas

Title to be announced
R. Michael Angelo, Stanford University, Stanford, California

Short talks from proffered abstracts

Break
9:45-10:15 A.M.
CME Icon
Plenary Session 8: Microenvironment
Session Chair: Lisa Coussens, OHSU Knight Cancer Center, Portland, OR
10:15 A.M.-12:30 P.M.

Title to be announced
Alexander D. Borowsky, University of California-Davis, Davis, California

Myoepithelial cell differentiation as a harbinger of DCIS progression and potential target for prevention
Pepper Schedin OHSU, Portland, Oregon

Title to be announced
Kornelia Polyak Dana-Farber Cancer Institute, Boston, Massachusetts

Short talks from proffered abstracts

CME Icon
Closing Keynote
Laura J. Esserman, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
12:30-1 p.m.
Closing Remarks
1 P.M.